You are here

Home

Innavasc Medical, Inc.

Company Information
Address
110 Swift Ave
Durham, NC 27705-4880
United States


http://www.innavasc.com
Information

UEI: GSH6GDCYLQN5

# of Employees: 4
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 5

  1. SBIR Phase II: Development of a novel graft to provide safe and reliable vascular access for hemodialysis patients

    Amount: $749,943.00

    The broader/commercial impact of this Phase II Small Business Innovation Research (SBIR) project will advance the development of a device to eliminate complications associated with maintenance hemodia ...

    SBIRPhase II2020National Science Foundation

  2. A Bullet Proof vascular graft to prevent dialysis access cannulation injury

    Amount: $2,999,008.00

    PROJECT SUMMARY End Stage Renal Disease (ESRD) affects more 750,000 individuals in the United States alone. Hemodialysis (HD) is a life-sustaining therapy for patients suffering from renal failure tha ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health

  3. SBIR Phase I: Development of a novel graft to provide safe and reliable vascular access for hemodialysis patients

    Amount: $224,975.00

    This SBIR Phase I project will advance the development of a novel arteriovenous graft that will minimize injury and decrease the probability of serious complications for chronic hemodialysis patients. ...

    SBIRPhase I2019National Science Foundation

  4. A Bullet Proof vascular graft to prevent dialysis access cannulation injury

    Amount: $1,998,507.00

    PROJECT SUMMARY End Stage Renal DiseaseESRDis a complex disease that involves total and permanent kidney failure that affects moreindividuals in the United States aloneHemodialysis is a life sustainin ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health

  5. A Bullet Proof vascular graft to prevent dialysis access cannulation injury

    Amount: $150,000.00

    Project Summary Abstract Synthetic arteriovenous grafts AVGs can provide life sustaining vascular access for dialysis patients but are subject to multiple modes of failure and complications related ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government